Life Cycle Management
End-to-end product lifecycle support
We provide comprehensive support to ensure your medicinal products remain safe, compliant, and competitive from their first approval through to discontinuation. Our Life Cycle Management (LCM) services bridge the gap between initial launch and long-term market success by expanding product value while maintaining rigorous regulatory standing.
Our expertise spans the full operational spectrum including CMC variations, pharmacovigilance (PV), Post-Market Surveillance (PMS), and batch release. Whether you require recurring support for Annual Reports (AR) and eIFU updates or specialized ad-hoc consultancy, we manage the technical and clinical complexities of your portfolio. From late-stage development to global supply chain maintenance, we ensure your product remains available to patients and fully aligned with evolving global standards.
Sustained value through strategic lifecycle management
QbD Group's lifecycle management solution ensures your products remain compliant and competitive from approval through maturity. We combine regulatory expertise, quality oversight, and commercial awareness to help you make informed decisions at every stage of the product lifecycle.
Our support spans CMC variations and dossier maintenance, pharmacovigilance, post-market surveillance, batch release, Annual Reports, and eIFU updates — providing both recurring operational support and specialized ad-hoc consultancy to manage the full complexity of your pharmaceutical portfolio.
Key challenges we address
Regulatory complexity
Managing ongoing CMC variations, renewals, and post-approval changes across multiple markets requires sustained regulatory expertise and coordination.
Pharmacovigilance obligations
Continuous safety monitoring, signal detection, PSUR preparation, and risk management plan updates demand dedicated expertise and infrastructure.
Commercial pressure
Balancing lifecycle optimization with cost efficiency while maintaining compliance and market authorization across territories.
Supply chain changes
Managing supplier changes, site transfers, and manufacturing variations while maintaining batch release continuity and GMP compliance.
Our structured approach
Lifecycle Assessment
Evaluate your product portfolio, identify optimization opportunities, and define a strategic lifecycle roadmap.
CMC Variations & Dossier Maintenance
Manage post-approval CMC changes, variations, renewals, and regulatory submissions efficiently across all target markets.
Pharmacovigilance & Safety
QPPV services, signal detection, PSUR preparation, risk management plans, and ongoing safety monitoring and reporting.
Batch Release & Supply Continuity
QP batch release, supply chain oversight, site transfer management, and Annual Report preparation to maintain uninterrupted market presence.
Our integrated offerings
Our integrated offerings support organizations across their full operational lifecycle, from compliance activities to sustained control, improvement, and digital enablement.
Sustained value across your product lifecycle
From CMC variations and pharmacovigilance to batch release and Annual Reports — we manage the full complexity of your pharmaceutical portfolio.
What you gain
Portfolio optimization
Strategic insights to maximize the commercial and regulatory value of your product portfolio across its full lifecycle.
Compliance continuity
Sustained regulatory, PV, and quality compliance across markets — from CMC variations to batch release and safety monitoring.
Reduced operational burden
Expert management of variations, renewals, pharmacovigilance, and post-approval changes so your team can focus on core operations.
Supply chain resilience
Proactive management of manufacturing changes, site transfers, and supplier variations to maintain uninterrupted market presence.
Why QbD Group
Your single partner for sustained pharmaceutical lifecycle management — from CMC variations and pharmacovigilance to batch release and portfolio optimization.
Full-spectrum lifecycle services
CMC variations, pharmacovigilance, PMS, QP batch release, Annual Reports, and eIFU updates managed under one roof
QPPV and safety expertise
signal detection, PSUR/PBRER preparation, risk management plans, and safety database management by experienced professionals
QP batch release continuity
compliant release in line with EMA directives, with supply chain oversight and site transfer management
Strategic portfolio optimization
maximize the commercial and regulatory value of your product portfolio across its full lifecycle
Scalable operational support
from recurring lifecycle services to specialized ad-hoc consultancy, adapting to your portfolio needs
How we support your product lifecycle
QbD Group ensures your products remain compliant, competitive, and available to patients from approval through maturity
Regulatory Lifecycle Services
CMC variations, renewals, and dossier maintenance.
- Post-approval change management
- Renewal submissions and lifecycle planning
- eIFU updates and regulatory documentation
Pharmacovigilance & Safety
Continuous safety monitoring and risk management.
- QPPV and local PV representative services
- Signal detection and PSUR preparation
- Safety database and case processing
Batch Release & Operations
QP batch release and supply chain continuity.
- Qualified Person batch release
- Annual Reports and periodic updates
- Site transfer and supplier management
FAQ
Frequently asked questions
Need lifecycle management support?
Partner with QbD Group to optimize your pharmaceutical product lifecycle — from CMC variations and pharmacovigilance to batch release and Annual Reports.